机构名称：
¥ 2.0
The Nevada Department of Health and Human Services (DHHS or the Department) is required to compile a list of prescription drugs essential for treating diabetes (Essential Diabetic Drugs or EDDs), a list of those Essential Diabetic Drugs that were subject to a price increase that met criteria, as well as a list of any other medication subject to a price increase that met criteria and cost more than $40 per course of therapy in Nevada (NRS 439b.630）。这些列表的最终版本于2023年2月1日发布。这些列表可以在此处查看：内华达州药物透明药物清单2023（NV.GOV）
2023药物透明度报告
主要关键词
相关文件推荐
